OSR HEALTH, INC. Depreciation
OSR HEALTH, INC. (OSRH) reported Depreciation of $17.51 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- OSR HEALTH, INC. depreciation for the quarter ending 2026-06-30 was $9.61K, a 4625.59% increase year-over-year.
- OSR HEALTH, INC. depreciation for the quarter ending 2026-03-31 was $7.90K, a 1991.44% increase year-over-year.
- OSR HEALTH, INC. depreciation for the quarter ending 2025-12-31 was $6.38K.
- OSR HEALTH, INC. depreciation for the quarter ending 2025-09-30 was $313.00, a 99.29% decline year-over-year.
- OSR HEALTH, INC. depreciation for fiscal 2025 was $7.27K, a 23.20% increase from fiscal 2024.
- OSR HEALTH, INC. depreciation for fiscal 2024 was $5.90K.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $9.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $17.51K 10-Q · filed 2026-08-14 | $23.88K derived: sum of 3 quarters · filed 2026-08-14 | $24.20K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $7.90K 10-Q · filed 2026-05-13 | $14.27K derived: sum of 2 quarters · filed 2026-05-13 | $14.59K derived: sum of 3 quarters · filed 2026-05-13 | $14.79K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $6.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $6.69K derived: sum of 2 quarters · filed 2026-03-31 | $6.89K derived: sum of 3 quarters · filed 2026-08-14 | $7.27K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $313.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $516.32 derived: sum of 2 quarters · filed 2026-08-14 | $894.00 10-Q · filed 2025-11-12 | -$41.05K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $203.32 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $581.00 10-Q · filed 2026-08-14 | -$41.37K derived: sum of 3 quarters · filed 2026-08-14 | $2.55K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $377.68 10-Q · filed 2026-05-13 | $378.00 10-Q · filed 2025-05-20 | -$41.57K derived: sum of 2 quarters · filed 2026-05-13 | $2.34K derived: sum of 3 quarters · filed 2026-05-13 | -$10.66K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$41.95K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.97K derived: sum of 2 quarters · filed 2026-03-31 | -$11.04K derived: sum of 3 quarters · filed 2026-03-31 | $5.90K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $43.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $30.91K derived: sum of 2 quarters · filed 2025-11-12 | $47.85K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $3.94K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $16.94K 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |